Join the Entrepreneurship Special Interest Group for a conversation with entrepreneur, Richard DiMarchi to gain insight into the path of successful entrepreneurship. The primary focus of the discussion will be on the unique and yet overlapping research activities observed across the development value chain that typically progresses from academic laboratories to transitional biotechnology start-ups to development-focused international pharmaceutical companies. What are the common and yet distinguishing technical and personal characteristics that distinguish scientists that have proven successful in each of these research environments?

Speaker: Richard DiMarchi, PhD
Distinguished Professor of Chemistry and Gill Chair of Biomolecular Sciences, Indiana University
Former Group Vice President, Eli Lily
Former Group Vice President, Novo Nordisk
National Inventors Hall of Fame Inductee

Moderator: Mark Heiman, PhD
CSO, Scioto Biosciences Inc. Former
Former CSO Microbiome Therapeutics

1. Gain insight on what distinguishes successful science in academics, biotech, and pharmaceutical companies.
2. Learn tips on launching and transitioning successful startup business.
3. Hear Dr. DiMarchi’s firsthand experience partnering drug candidates with pharmaceutical companies and how to best approach that process.